Event Recordings

Day 1  |  Day 2

Day 1: Monday, April 19, 2021

Day 1 Welcome

Joseph Wu, MD, PhD
Director, Stanford Cardiovascular Institute; Simon H. Stertzer, MD, Professor of Medicine and Radiology, Stanford University

Marc Tessier-Lavigne, PhD
President, Stanford University

Lloyd Minor, MD
Dean, Stanford School of Medicine



Session I: Biology of Disease

Moderators: Helen Blau, PhD, and Mark Mercola, PhD

New Paradigms in Drug Discovery

Roger Kornberg, PhD, Mrs. George A. Winzer Professor in Medicine, Stanford University; Nobel prize in 2006

Toward a Single-dose, Room-temperature Stable COVID-19 Vaccine

Peter Kim, PhD, Virginia and D.K. Ludwig Professor of Biochemistry, Stanford University

Session II: Investing in Discovery

Moderators: Nina Kjellson and Kuldev Singh, MD

Voice of the Body: The Data Journey

Young Sohn, MS, Chairman of the Board, HARMAN and Senior Advisor, Samsung Electronics

Breaking Through Impossible

Jürgen Eckhardt, MD, Head of Leaps by Bayer

Venture and Growth Technology and Healthcare at Scale

Carmen Chang, MA, JD, General Partner; Head of Asia, New Enterprise Associates

Venture Investment in Drug Discovery – A European Perspective

Nanna Lüneborg, PhD, MBA, Partner, Novo Ventures

Panel Discussion

Moderators: Nina Kjellson and Kuldev Singh, MD

Featuring:

Jürgen Eckhardt, MD
Head of Leaps by Bayer

Young Sohn, MS
Chairman of the Board, HARMAN and Senior Advisor, Samsung Electronics

Carmen Chang, MA, JD
General Partner; Head of Asia, New Enterprise Associates

Nanna Lüneborg, PhD, MBA
Partner, Novo Ventures

Session III: Discovery Research I

Moderators: Sandra Horning, MD, and Sanjay Malhotra, PhD

Making Medicines – A Partnership

Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing, Gilead

RNA Targeted Drug Discovery: From Pipe Dream to Reality

Stanley T. Crooke, MD, PhD, Ionis Pharmaceuticals Executive Chairman of the Board

Re-defining the Novo Nordisk Approach to Drug Discovery

Marcus Schindler, PhD, Executive Vice President and CSO of Research & Early Development, Novo Nordisk

Human Genetics, Functional Genomics and AI/ML in Drug Discovery

Hal Barron, MD, CSO and President, GlaxoSmithKline

Drug Discovery: Where are We Headed?

Wendy Young, PhD, Senior Vice President, Small Molecule Drug Discovery, Genentech

Panel Discussion

Moderators: Sandra Horning, MD, and Sa­­njay Malhotra, PhD

Featuring:

Taiyin Yang, PhD
Executive Vice President, Pharmaceutical Development and Manufacturing, Gilead

Stanley T. Crooke, MD, PhD
Ionis Pharmaceuticals Executive Chairman of the Board

Marcus Schindler, PhD
Executive Vice President and CSO of Research & Early Development, Novo Nordisk

Hal Barron, MD
CSO and President, GlaxoSmithKline

Wendy Young, PhD
Senior Vice President, Small Molecule Drug Discovery, Genentech

Session IV: Disseminating Drug Discovery Findings

Moderators: Amanda Chase, PhD, and Mark Mercola, PhD

Panel Discussion

Featuring:

Michael Basson, PhD
Senior Editor, Nature Medicine

Orla Smith, PhD
Editor, Science Translational Medicine

Michael Nedelman
CNN Producer

Session V: Presentation of Lifetime Achievement Awards

Moderator: Philip Pizzo, MD

Presentation of Lifetime Achievement Awards

Philip Pizzo, MD, David and Susan Heckerman Professor and Professor of Microbiology and Immunology, Stanford University

Virus-like Particle Vaccination for Preventing HPV-Associated Cancers

Douglas R. Lowy, MD, Principal Deputy Director, National Cancer Institute

Moving Beyond Personalized Therapies for Cancer

John T. Schiller, PhD, Deputy Chief, Laboratory of Cellular Oncology

Q&A Session

Featuring:

Douglas R. Lowy, MD
Principal Deputy Director, National Cancer Institute

John T. Schiller, PhD
Deputy Chief, Laboratory of Cellular Oncology

Mathai Mammen, MD, PhD
Global Head of Research and Development, Janssen

Yvonne Maldonado, MD
Sr Associate Dean, Faculty Development and Diversity, Taube Professor of Global Health and Infectious Diseases

Day 1 Closing Remarks

Joseph Wu, MD, PhD, Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor of Medicine and Radiology, Stanford University